Identification and Quantification of Oligodendrocyte Precursor Cells in Multiple System Atrophy, Progressive Supranuclear Palsy and Parkinson's Disease
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Multiple system atrophy is a neurodegenerative disorder characterized pathologically by abnormal accumulations of α‐synuclein in the cytoplasm of oligodendrocytes, which are termed glial cytoplasmic inclusions (GCIs). Oligodendrocytes are responsible for myelinating axons and providing neurotrophic support, but in MSA, myelin loss, axonal loss and gliosis are consistent features suggesting that GCIs play a central role in disease pathogenesis. Oligodendroglial, myelin and axonal degeneration are also features of multiple sclerosis (MS) in which recent studies have highlighted the robust remyelination capacity of the central nervous system (CNS). The cells responsible for remyelination are called oligodendroglial precursor cells (OPCs). In this study, we investigated the role of OPCs in the pathogenesis of MSA and progressive supranuclear palsy (PSP), a neurodegenerative disease in which neuropathological changes include oligodendroglial inclusions composed of microtubule‐associated protein tau. Despite the lability of OPC‐specific antigens, we successfully identified OPCs and demonstrated that tau and α‐synuclein do not accumulate in OPCs. We also showed that the density of OPCs was increased in a white matter region of the MSA brain, which is also severely affected by GCIs and myelin degeneration. These findings raise the possibility that OPCs could be available to repair disease‐associated damage in MSA, consistent with their biological function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544 · cited 8×
“The CNS has an innate ability for remyelination and this has been an area of intense research interest in the field of MS (6, 11).”
BackgroundResultInfluentialPapp, M. I., Kahn, J. E., & Lantos, P. L. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90219-0 · Cited by 991 · cited 2×
“Neurodegeneration is associated with the accumulation of a-synuclein in the cytoplasm of oligodendrocytes (27), termed glial cytoplasmic inclusions (GCIs) or Papp-Lantos bodies, the hallmark lesion of MSA (18).”
BackgroundPolydendrocytes (NG2 cells): multifunctional cells with lineage plasticity
Nishiyama, A., Komitova, M., Suzuki, R., & Zhu, X. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2495 · Cited by 865 · cited 9×
“Double immunofluorescence labeling using NG2 (green) and disease-associated markers a-synuclein and tau (red) demonstrated that glial cytoplasmic inclusions in MSA (A, arrows heads) and that coiled bodies (B, arrows heads) and tufted astrocytes (C, arrow head) in PSP are NG2-negative.”
BackgroundInfluentialα-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy
Wakabayashi, K., Yoshimoto, M., Tsuji, S., & Takahashi, H. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00407-8 · Cited by 643
Papp, M. I., & Lantos, P. L. (1994) · Brain · doi:10.1093/brain/117.2.235 · Cited by 389
Hyperphosphorylation and insolubility of α‐synuclein in transgenic mouse oligodendrocytes
Kahle, P. J., Neumann, M., Ozmen, L., Müller, V., Jacobsen, H., Spooren, W., Fuss, B., Mallon, B., Macklin, W. B., Fujiwara, H., et al. (2002) · The EMBO Reports · doi:10.1093/embo-reports/kvf109 · Cited by 314
Yazawa, I., Giasson, B. I., Sasaki, R., Zhang, B., Joyce, S., Uryu, K., Trojanowski, J. Q., & Lee, V. M.-Y. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.032 · Cited by 301
Inflammation, demyelination, and degeneration — Recent insights from MS pathology
Stadelmann, C., Wegner, C., & Brück, W. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.007 · Cited by 276 · cited 1×
“Multiple sclerosis (MS) is considered an inflammatory demyelinating disease of the central nervous system (CNS) and shows some similarities with MSA in that there is also evidence of oligodendroglial involvement, myelin degeneration, axonal loss and gliosis (24).”
BackgroundAbsence of α-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia
Miller, D. W., Johnson, J. M., Solano, S. M., Hollingsworth, Z. R., Standaert, D. G., & Young, A. B. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0378-1 · Cited by 198 · cited 1×
“Although highly speculative at this juncture, our hypothesis would explain (i) how a-synuclein accumulates in more mature oligodendrocytes that have been shown to have no or very little endogenous a-synuclein expression (14, 21); (ii) why NG2positive OPCs do not accumulate a-synuclein in MSA (as shown in this study);…”
Cited by
Poewe, W., Stankovic, I., Halliday, G., Meissner, W. G., Wenning, G. K., Pellecchia, M. T., Seppi, K., Palma, J.-A., & Kaufmann, H. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00382-6 · Cited by 279
Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?
Ettle, B., Schlachetzki, J. C. M., & Winkler, J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9205-3 · Cited by 160
“studies recently reported increased numbers of OPCs in MSA patients [182, 183].”
BackgroundDjelloul, M., Holmqvist, S., Boza-Serrano, A., Azevedo, C., Yeung, M. S., Goldwurm, S., Frisén, J., Deierborg, T., & Roybon, L. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.07.002 · Cited by 138
“Whether ASYN expression identified in these two studies is reminiscent of a basal expression in quiescent OPCs, and the difference although not significant identified in oligodendrocytes fromMSA and control samples is the result of a greater oligodendrogenesis probably triggered by neuronal injury (Ahmed et al., 2013)…”
Intracellular alpha-synuclein affects early maturation of primary oligodendrocyte progenitor cells
Ettle, B., Reiprich, S., Deusser, J., Schlachetzki, J. C. M., Xiang, W., Prots, I., Masliah, E., Winner, B., Wegner, M., & Winkler, J. (2014) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2014.06.012 · Cited by 57
Changes in the cell population in brain white matter in multiple system atrophy
Nykjær, C. H., Brudek, T., Salvesen, L., & Pakkenberg, B. (2017) · Movement Disorders · doi:10.1002/mds.26979 · Cited by 51
“Mean [range] 4/6 65 [61-70] 614 [533-703] 49 [22-115] 4/6 7/4 59 [54-63] 6.”
Metadata
- Authors
- Ahmed, Z., Asi, Y. T., Lees, A. J., Revesz, T., & Holton, J. L.
- Venue
- Brain Pathology
- Publisher
- Wiley
- Published
- 2012-10-23
- Volume
- 23
- Issue
- 3
- Pages
- 263-273
- ISSN
- 1015-6305 (ISSN-L)
- 1750-3639
- OpenAlex
- W2146858419
- Cited by
- 92
- References
- 12
- FWCI
- 3.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identification and Quantification of Oligodendrocyte Precursor Cells in Multiple System Atrophy, Progressive Supranuclear Palsy and Parkinson's Disease. https://app.cochat.ai/papers/10.1111/j.1750-3639.2012.00637.x
- The paper
- Ahmed, Z., Asi, Y. T., Lees, A. J., Revesz, T., & Holton, J. L. (2013). Identification and Quantification of Oligodendrocyte Precursor Cells in Multiple System Atrophy, Progressive Supranuclear Palsy and Parkinson's Disease. Brain Pathology. https://doi.org/10.1111/j.1750-3639.2012.00637.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.